Sienna Biopharmaceuticals, Inc.
SNNAQ
$0.00
$0.000.00%
OTC PK
| 09/30/2019 | 06/30/2019 | 03/31/2019 | 12/31/2018 | 09/30/2018 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -82.29% | -34.29% | -4.74% | -34.84% | -27.79% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 181.98% | -52.23% | -39.99% | -36.81% | 42.03% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 17.68% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Current Assets | -70.58% | -34.81% | -5.97% | -34.82% | -26.17% |
|
|
|||||
| Total Current Assets | -70.58% | -34.81% | -5.97% | -34.82% | -26.17% |
| Net Property, Plant & Equipment | -24.35% | 155.80% | 163.73% | -28.01% | -6.25% |
| Long-term Investments | -- | -2.86% | -8.92% | -4.21% | -1.76% |
| Goodwill | -- | -2.86% | -8.92% | -4.21% | -1.76% |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -49.04% | -2.86% | -8.92% | -4.21% | -1.77% |
| Total Assets | -65.10% | -20.70% | -6.87% | -21.59% | -16.61% |
|
|
|||||
| Total Accounts Payable | -47.48% | -63.59% | 17.02% | 18.46% | 120.33% |
| Total Accrued Expenses | -71.50% | -47.16% | -28.36% | 38.76% | 44.24% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -78.87% | 6,600.47% | 6,895.31% | 5,836.36% | -95.67% |
| Total Other Current Liabilities | -78.87% | 6,600.47% | 6,895.31% | 5,836.36% | -95.67% |
| Total Current Liabilities | -64.30% | 55.96% | 146.20% | 195.46% | 2.21% |
|
|
|||||
| Total Current Liabilities | -64.30% | 55.96% | 146.20% | 195.46% | 2.21% |
| Long-Term Debt | -66.30% | -1.41% | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -85.08% | -19.31% | -22.39% | -29.82% | -9.19% |
| Total Liabilities | -74.42% | 0.57% | 73.53% | 76.84% | 50.23% |
|
|
|||||
| Common Stock & APIC | 15.85% | 19.33% | 19.81% | 6.42% | 8.84% |
| Retained Earnings | -34.27% | -49.34% | -70.67% | -85.53% | -87.44% |
| Treasury Stock & Other | -66.20% | -34.78% | -67.59% | -40.43% | -17.96% |
| Total Common Equity | -48.58% | -51.41% | -56.45% | -70.85% | -53.39% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -48.58% | -51.41% | -56.45% | -70.85% | -53.39% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -48.58% | -51.41% | -56.45% | -70.85% | -53.39% |
|
|
|||||